Veritas Pharma Inc. announced earnings results for the third quarter ended January 31, 2020. For the third quarter, the company announced net loss was CAD 256,074 compared to CAD 853,206 a year ago. Basic loss per share was CAD 0.02 compared to CAD 0.09 a year ago. For the nine months, net loss was CAD 1.409 million compared to CAD 3.851 million a year ago. Basic loss per share was CAD 0.12 compared to CAD 0.48 a year ago.